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Introduction
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS). Approx imately 2.5 million people currently live with MS glo bally. Susceptibility to MS varies in different ethnic groups, with people of Scottish origin being more like ly to develop the disease [5] . Family members of MS patients have a higher risk of developing the disease than individuals without a family history [1] .
Multiple sclerosis lesions are characterized by in flammatory demyelination and reactive gliosis, and although remyelination occurs in some lesions it is limited and incomplete. Possible reasons for this abortive remyelination include astrogliosis and accu mulation of extracellular matrix, lack of myelinating Communicating author:
Professor Farhad Mashayekhi, Department of Biology, Faculty of Sciences, University of Guilan, Rasht, Iran, phone: 00989113330017, fax: 00981313233647, email: umistbiology@yahoo.co.uk cells or an unfavorable combination of growth fac tors. Growth factor expression could participate in the repair process of this demyelinating disease by mod ulating the activity of microglia/macrophages in an autocrine fashion, by inducing the expression of other factors that can affect myelin regeneration or degen eration, and also by directly stimulating the localized proliferation and/or regeneration of oligodendro cytes within lesion areas [21] . It has been shown that one of the identified proteins, transmembrane protein 10 (Tmem10; also known as Opalin or oligo dendrocyte paranodal loop protein), whose expres sion is specific to the brain, predominantly localized in many white matter regions and was upregulated during the postnatal developmental stages [2] . It was shown that Opalin protein is specifically expressed by myelinating oligodendrocytes, suggesting that it plays a unique role in mammalian myelin [11] . In the CNS the main proteins of myelin are proteolipid protein (PLP), myelin basic protein (MBP) and myelin oligo dendrocyte glycoprotein (MOG). Myelin oligodendro cyte glycoprotein is a minor component of the myelin sheath, but it is an important autoantigen linked to the pathogenesis of MS. It has been shown that MOG is a potent encephalitogen that triggers strong T cell and B cell responses. It has been recently shown that MOG antibodies could be associated with a broad spectrum of acquired human CNS demyelinating dis eases [20] .
Cytokines and growth factor play important roles in brain development and function [14, 15] . Growth factor expression could participate in the repair process of demyelinating disease by modulating the activity of microglia/macrophages, inducing the expression of other factors that can affect myelin regeneration or degeneration, and also by directly stimulating the localized proliferation and/or regen eration of oligodendrocytes within lesion areas [21] . Among growth factors, leukemia inhibitory factor (LIF) is a cytokine that has been demonstrated to play an important role in neural cell survival, includ ing cholinergic neurons. It has been demonstrated that LIF limits autoimmune demyelination and oligo dendrocyte loss in a murine model of MS [7] . Leuke mia inhibitory factor promotes the differentiation of either neurons or astrocytes depending on the cul ture conditions [19] . Increased LIF concentration in the cerebrospinal fluid (CSF) of patients with MS has been demonstrated [16] . It has been suggested that LIF is a potential therapeutic candidate for MS [23] .
Leukemia inhibitory factor binds to a heterodi meric membrane receptor complex consisting of LIF receptor (LIFR) and glycoprotein 130 (gp120) [25] . Leukemia inhibitory factor receptor has been shown to be expressed in the dorsal ventricular zone and subventricular zone of the cerebral cortex [4] . Coop erative expression of LIF and LIFR in the brain of patients with neurodegenerative disease including Parkinson's disease (PD) and Alzheimer's disease (AD) may indicate a role for LIF in neuronal damage or repair in these diseases [24] . It was shown that LIF delivery to oligodendrocyte progenitor cells (OPCs) stimulates their proliferation through the activation of gp130 receptor signaling within these cells, and it has been suggested that LIF has both reparative and protective activities that make it a promising potential therapy for CNS demyelinating disorders and injuries [9] . It has been shown that LIF is a neu rotrophic cytokine and plays an important role in neural cell survival and myelin formation in vitro [13] . It has been shown that suppressing expression of CNTF, which is an LIF family, plays a key role in the remyelination process in cuprizoneinduced demye linated mouse [26] . Addition of LIF neutralizing anti bodies inhibited oligodendrocyte differentiation, indicating a crucial role of TNFR2induced astrocyte derived LIF for oligodendrocyte maturation [10] .
As Opalin is a unique molecular marker for mature oligodendrocytes and MOG is a component of the myelin sheath which is an important autoan tigen linked to the pathogenesis of MS [11, 20] , we aimed to examine the in vivo effects of LIF on the remyelination process in the cerebral cortex of the cuprizoneinduced MS mouse.
Material and methods

Animals
Balb/c mice were purchased from Pasteur Insti tute, Tehran, Iran and maintained on a 1212 light: dark cycle beginning at 8.00 am. They were kept at a constant temperature in mouse boxes with unre stricted access to laboratory food and water. The col ony was maintained through random pair mating. Timed mating was ca rried out by placing a male and female together and checking for the presence of a vaginal plug. The presence of a vaginal plug was taken as gestational day zero (E0) and the day of birth was designated postnatal day 0 (P0).
Induction of demyelination and treatment with leukemia inhibitory factor
Demyelination was induced by feeding 810week old mice a diet containing 0.2% cuprizone (biscyclo hexanone oxaldihydrazone, SigmaAldrich Inc.) mixed into ground standard rodent chow.
The cuprizone diet was administered for 5 weeks for demyelination. The control group received breed er chow without the cuprizone admixture. Animals were then put on standard rodent chow without cuprizone to induce remyelination. The mice were then divided into three groups. The first group was injected intraperitoneally (IP) with LIF for 6 weeks in the amount of 30 µg/kg bw per day. The second group (SHAM) was injected with normal saline and the third group was left without injection as the con trol group. After four weeks the cerebral cortex was harvested after euthanasia by intraperitoneal injec tion of an overdose of anesthetic (sodium pentobar bitone) and the cerebral cortex was removed and processed as described. In total, 42 animals were used in this study (n = 14 for each group).
Cell extract
Fresh tissue samples (10 mg each) were chopped into tiny pieces and suspended in 0.5 ml of protein lysis buffer [150 mM NaCl, 1.0% NP40, 20 mM Tris (pH 7.5), 5 mM EDTA, and Complete Mini protease inhibitor cocktail (Roche Diagnostics Ltd., West Sus sex, UK)] and then mechanically homogenized by sonication. After centrifugation, the protein extracts were recovered and stored at -70°C until they were used.
Total protein concentration and western blotting
The total protein concentration in the cerebral cortex extracts was determined by the BioRad protein assay based on the Bradford dye proce dure. For western blot, protein extracts (50 µg/lane) were separated on 10% SDSpolyacrylamide gel and transferred to a polyvinylidene difluoride mem brane (BioRad Laboratories Ltd. Hertfordshire, UK). The membranes were blocked with phosphatebuff ered saline (PBS) containing 0.05% Tween 20 and 5% dry milk and probed either with polyclonal antiOpalin antibody (Santa Cruz Biotechnology; sc135362) (1 : 1000 dilution), polyclonal antiMOG antibody or a mouse monoclonal antiβtubulin anti body (as a loading control) (Abcam plc, Cambridge, UK) (1 : 10,000 dilution) and then treated with the appropriate horseradish peroxidaseconjugated secondary antibodies. Immunoreactive protein was visualized using the Enhanced Chemiluminescence western blotting detection system (Amersham Phar macia Biotech, Piscataway, NJ). Densitometric anal ysis was performed by scanning immunoblots and quantitating protein bands using an image analyzer (Metaview Software).
Statistical analysis
All data presented are expressed as mean ± stan dard error of the mean (SEM). Statistical analysis was performed using the oneway ANOVA to test for differences among the groups, and only values with p ≤ 0.05 were considered significant.
Results
Total protein concentration
The total protein concentration in the cerebral cortex extracts from LIF injected, SHAM and control groups was determined by the BioRad protein assay based on the Bradford dye mixture. The total pro tein contents of LIF injected, SHAM and control were 1.11 ± 0.12, 1.07 ± 0.18 and 1.05 ± 0.18 (g/l), respec tively. No significant increase in the total protein concentration was seen in the LIFinjected brain samples compared with those from the SHAM and control groups (p > 0.05).
Analysis of Opalin and myelin oligodendrocyte glycoprotein expression by western blotting
Western blot analysis was performed to quanti tatively evaluate Opalin and MOG expression in the cerebral cortical extracts. A western blot analysis using antiOpalin and MOG antibodies as a probe confirmed the presence of Opalin and MOG in all the extracts (Fig. 1A and Fig. 2A ). An image analyzer was used to determine the intensities of the band in the res pective lanes. Quantification of the western blot bands from repeated experiments (n = 14) showed that the amount of Opalin and MOG was significantly increased in the LIFinjected cerebral cortical extracts when compared with SHAM and control groups (p < 0.0001) (Fig. 1B and Fig. 2B ).
Discussion
Acute demyelination of the CNS in MS is initial ly followed by a process of remyelination [3] . This repair process is guaranteed by the extensive prolif eration of oligodendrocyte progenitor cells (OPCs) in response to demyelination. It has been demonstrat ed that growth factor expression could be important in the repair process of this demyelinating disease by modulating the activity of microglia/macrophages by inducing the expression of other factors that can affect myelin regeneration and also by directly stim ulating the localized proliferation and/or regenera tion of oligodendrocytes within lesion areas.
Among growth factors, LIF has been shown to play an important role in neural cell survival [8] . Leu kemia inhibitory factor has been demonstrated to limit autoimmune demyelination and oligodendro cyte loss in a murine model of MS [6] . Spinal cord precursors also synthesize LIF, and antiLIFRβ anti bodies completely blocked the generation of neu rons. Leukemia inhibitory factor plays an important role in generation, maturation and survival of oligo dendrocytes [17] . Data supporting a neuroprotective role of LIF have been obtained in MS, where LIF has been demonstrated to be produced by myelinreac tive T cells isolated from MS patients and protect [27] .
We investigated LIF as it is one of the most import ant growth factors involved in the survival of oligo dendrocytes [12] . Leukemia inhibitory factor contrib utes to differentiation of the glial cell lineage [18] .
The role of ciliary neurotrophic factor (CNTF) in the process of remyelination has been demonstrat ed [22] . Here we show that daily administration of LIF significantly increases MOG and Opalin expres sion in the cuprizoneinduced mouse cerebral cortex. As Opalin is a unique molecular marker for mature oligodendrocytes, the increased Opalin expression in the cerebral cortex of LIF injected mouse may be due to increased differentiation of oligodendrocyte progenitor cells into mature oligodendrocytes. We have also shown that LIF increases MOG expression in the cerebral cortex, which indicates the role of LIF in myelin formation. The results of this study could have been anticipated with some certainty given the findings of other studies that have investigated the role of LIF in MS.
It is thus concluded that LIF may have an import ant role in the process of remyelination by increasing either Opalin expression and oligodendrocyte differ entiation or MOG expression. It is also suggested that LIF may have an important role in the process of remyelination by increasing MOG expression in the cerebral cortex.
